Form 8-K - Current report:
SEC Accession No. 0001625297-25-000046
Filing Date
2025-06-30
Accepted
2025-06-30 07:03:38
Documents
13
Period of Report
2025-06-30
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K indv-20250630.htm   iXBRL 8-K 28239
2 EX-99.1 ex991russellpressrelease.htm EX-99.1 12566
  Complete submission text file 0001625297-25-000046.txt   159147

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT indv-20250630.xsd EX-101.SCH 1773
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT indv-20250630_lab.xml EX-101.LAB 21615
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT indv-20250630_pre.xml EX-101.PRE 12502
15 EXTRACTED XBRL INSTANCE DOCUMENT indv-20250630_htm.xml XML 2737
Mailing Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE
Business Address 234 BATH ROAD SLOUGH, BERKSHIRE X0 SL1 4EE 804-379-1090
INDIVIOR PLC (Filer) CIK: 0001625297 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37835 | Film No.: 251088730
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)